138.44
Schlusskurs vom Vortag:
$138.30
Offen:
$134.91
24-Stunden-Volumen:
172.76K
Relative Volume:
0.30
Marktkapitalisierung:
$3.97B
Einnahmen:
$267.23M
Nettoeinkommen (Verlust:
$-83.50M
KGV:
-44.51
EPS:
-3.11
Netto-Cashflow:
$-59.99M
1W Leistung:
-0.15%
1M Leistung:
+16.07%
6M Leistung:
+104.16%
1J Leistung:
+82.62%
Genedx Holdings Corp Stock (WGS) Company Profile
Firmenname
Genedx Holdings Corp
Sektor
Branche
Telefon
888-729-1206
Adresse
333 LUDLOW STREET, STAMFORD
Vergleichen Sie WGS mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
|
WGS
Genedx Holdings Corp
|
138.16 | 4.00B | 267.23M | -83.50M | -59.99M | -3.11 |
|
TMO
Thermo Fisher Scientific Inc
|
564.84 | 212.23B | 43.74B | 6.58B | 6.11B | 17.31 |
|
DHR
Danaher Corp
|
213.67 | 151.20B | 24.27B | 3.50B | 5.02B | 4.8589 |
|
IDXX
Idexx Laboratories Inc
|
720.99 | 57.84B | 4.04B | 985.66M | 774.34M | 12.01 |
|
A
Agilent Technologies Inc
|
146.69 | 41.02B | 6.79B | 1.22B | 1.09B | 4.2644 |
|
IQV
Iqvia Holdings Inc
|
212.53 | 36.42B | 15.90B | 1.28B | 2.21B | 7.2842 |
Genedx Holdings Corp Stock (WGS) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-10-20 | Eingeleitet | Canaccord Genuity | Buy |
| 2025-07-09 | Eingeleitet | Piper Sandler | Overweight |
| 2025-05-15 | Eingeleitet | Guggenheim | Buy |
| 2025-05-09 | Hochstufung | Jefferies | Hold → Buy |
| 2024-08-28 | Eingeleitet | Wells Fargo | Equal Weight |
| 2024-07-10 | Eingeleitet | Craig Hallum | Buy |
| 2024-06-03 | Fortgesetzt | Jefferies | Hold |
Alle ansehen
Genedx Holdings Corp Aktie (WGS) Neueste Nachrichten
GeneDx to Participate in Upcoming Investor Conferences - Business Wire
Corton Capital Inc. Invests $339,000 in GeneDx Holdings Corp. $WGS - MarketBeat
Key metrics from GeneDx Holdings Corp. Equity Warrant’s quarterly dataEarnings Beat & Low Drawdown Investment Strategies - newser.com
Can GeneDx Holdings Corp. stock deliver surprise earnings beatJobs Report & Growth Focused Investment Plans - newser.com
Real time pattern detection on GeneDx Holdings Corp. Equity Warrant stockFed Meeting & Daily Chart Pattern Signal Reports - newser.com
GeneDx Holdings Corp. $WGS Shares Sold by Hussman Strategic Advisors Inc. - MarketBeat
What moving averages say about GeneDx Holdings Corp. Equity WarrantJuly 2025 Opening Moves & Community Verified Watchlist Alerts - newser.com
Price action breakdown for GeneDx Holdings Corp. Equity Warrant2025 Institutional Moves & Consistent Growth Stock Picks - newser.com
Volume spikes in GeneDx Holdings Corp. stock – what they mean2025 Trade Ideas & High Win Rate Trade Tips - newser.com
Visual trend scoring systems applied to GeneDx Holdings Corp. Equity WarrantMarket Volume Report & Risk Adjusted Swing Trade Ideas - newser.com
How rising interest rates impact GeneDx Holdings Corp. stockTrade Signal Summary & Growth Oriented Trading Recommendations - newser.com
Will GeneDx Holdings Corp. Equity Warrant stock outperform international peersWeekly Trade Analysis & Capital Efficiency Focused Ideas - newser.com
Why GeneDx Holdings Corp. stock could be next big winnerForecast Cut & Technical Pattern Recognition Alerts - newser.com
Will GeneDx Holdings Corp. Equity Warrant stock continue dividend increasesJuly 2025 Chart Watch & High Accuracy Investment Entry Signals - newser.com
How high can GeneDx Holdings Corp. stock go2025 Valuation Update & Accurate Entry and Exit Point Alerts - newser.com
GeneDx Holdings Corp. stock prediction for this weekGlobal Markets & High Return Stock Watch Alerts - newser.com
Will GeneDx Holdings Corp. stock maintain growth storyTrade Signal Summary & Technical Pattern Alert System - newser.com
Heatmap analysis for GeneDx Holdings Corp. and competitorsMarket Activity Recap & Stepwise Entry and Exit Trade Signals - newser.com
Zweig DiMenna Associates LLC Buys 129,000 Shares of GeneDx Holdings Corp. $WGS - MarketBeat
Should you hold or exit GeneDx Holdings Corp. Equity Warrant nowJuly 2025 Volume & Technical Entry and Exit Tips - newser.com
Kovack Advisors Inc. Makes New Investment in GeneDx Holdings Corp. $WGS - MarketBeat
Can momentum traders help lift GeneDx Holdings Corp. Equity Warrant2025 Fundamental Recap & Expert Curated Trade Setup Alerts - newser.com
Is GeneDx Holdings Corp. stock a top pick in earnings seasonJuly 2025 News Drivers & Expert Verified Stock Movement Alerts - newser.com
Oppenheimer Asset Management Inc. Invests $236,000 in GeneDx Holdings Corp. $WGS - MarketBeat
Will GeneDx Holdings Corp. stock split again soonJuly 2025 Intraday Action & Community Consensus Stock Picks - newser.com
How GeneDx Holdings Corp. Equity Warrant stock performs in rising dollar environment - newser.com
Can momentum traders help lift GeneDx Holdings Corp.2025 Major Catalysts & High Accuracy Trade Alerts - newser.com
GeneDx Holdings (WGS) Is Up 6.2% After Raised Guidance and FDA Breakthrough Designation – What's Changed - simplywall.st
Can GeneDx Holdings Corp. stock resist market sell offsWeekly Market Summary & Safe Capital Allocation Plans - newser.com
Will GeneDx Holdings Corp. stock outperform tech sector in 2025Quarterly Risk Review & Weekly Stock Breakout Alerts - newser.com
Wall Street Zen Downgrades GeneDx (NASDAQ:WGS) to Hold - MarketBeat
GeneDx (NASDAQ:WGS) CFO Sells $52,977.52 in Stock - MarketBeat
GeneDx (NASDAQ:WGS) CEO Katherine Stueland Sells 2,158 Shares - MarketBeat
Is GeneDx Holdings Corp Equity Warrant a good long term investmentEarnings Forecast Updates & Outstanding Return Stocks - earlytimes.in
Price action breakdown for GeneDx Holdings Corp.Weekly Trend Report & Fast Entry High Yield Tips - newser.com
Jennison Associates LLC Has $36.73 Million Holdings in GeneDx Holdings Corp. $WGS - MarketBeat
Finanzdaten der Genedx Holdings Corp-Aktie (WGS)
Umsatz
Nettogewinn
Free Cashflow
ENV
Genedx Holdings Corp-Aktie (WGS) Insiderhandel
| Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
|---|---|---|---|---|---|---|---|
| Stueland Katherine | CHIEF EXECUTIVE OFFICER |
Oct 29 '25 |
Sale |
136.54 |
2,158 |
294,654 |
3,436 |
| Feeley Kevin | CHIEF FINANCIAL OFFICER |
Oct 29 '25 |
Option Exercise |
0.00 |
753 |
0 |
4,145 |
| Feeley Kevin | CHIEF FINANCIAL OFFICER |
Oct 29 '25 |
Sale |
136.54 |
388 |
52,978 |
3,757 |
| Stueland Katherine | CHIEF EXECUTIVE OFFICER |
Sep 30 '25 |
Sale |
108.17 |
12,858 |
1,390,911 |
1,720 |
| Feeley Kevin | CHIEF FINANCIAL OFFICER |
Sep 30 '25 |
Option Exercise |
32.67 |
1,246 |
40,707 |
10,001 |
| Feeley Kevin | CHIEF FINANCIAL OFFICER |
Sep 30 '25 |
Sale |
108.38 |
6,609 |
716,261 |
3,392 |
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):